Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: Findings from a randomised trial

European Journal of Cancer

Volumn 49, Issue 8, 2013, Pages 1923-1931

  Huang, Pei Yu ^a,b   Wang, Cheng Tao ^b   Cao, Ka Jia ^a,b   Guo, Xiang ^a,b   Guo, Ling ^a,b   Mo, Hao Yuan ^a,b   Wen, Bi Xiu ^b   Wu, Yi Shan ^a,b   Mai, Hai Qiang ^a,b   Hong, Ming Huang ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Body mass index; Chemoradiotherapy; Nasopharyngeal carcinoma

Indexed keywords

CARBOPLATIN; FLOXURIDINE;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BODY MASS; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FAILURE FREE SURVIVAL; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER DYSFUNCTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; OBESITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN MANIFESTATION; THROMBOCYTOPENIA; UNDERWEIGHT; VOMITING;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; CHEMORADIOTHERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOPENIA; MALE; MIDDLE AGED; MUCOSITIS; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); OVERWEIGHT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 84876694138     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.01.027     Document Type: Article

References (30)

1. B. Baujat, H. Audry, and J. Bourhis Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 64 1 2006 47 56
2. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 9403 2004 157 163
3. V. Mor, L. Laliberte, J.N. Morris, and M. Wiemann The Karnofsky performance status scale. An examination of its reliability and validity in a research setting Cancer 53 9 1984 2002 2007
4. K. Munstedt, M. Wagner, U. Kullmer, A. Hackethal, and F.E. Franke Influence of body mass index on prognosis in gynecological malignancies Cancer Causes Control 19 9 2008 909 916
5. P.C. Pai, C.C. Chuang, and C.K. Tseng Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation Int J Radiat Oncol Biol Phys 83 1 2012 e93 e100
6. S.M. Park, M.K. Lim, S.A. Shin, and Y.H. Yun Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study J Clin Oncol 24 31 2006 5017 5024
7. A.S. Parker, and C.M. Lohse Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma Urology 68 4 2006 741 746
8. L.H. Simkens, M. Koopman, and L. Mol Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy Eur J Cancer 47 17 2011 2560 2567
9. K.K. Mauland, J. Trovik, and E. Wik High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer Br J Cancer 104 6 2011 921 926
10. S. Dawood, K. Broglio, and A.M. Gonzalez-Angulo Prognostic value of body mass index in locally advanced breast cancer Clin Cancer Res 14 6 2008 1718 1725
11. J.A. Efstathiou, M.H. Chen, A.A. Renshaw, M.J. Loffredo, and A.V. D'Amico Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer Cancer 109 8 2007 1493 1498
12. M. Zhang, X. Xie, A.H. Lee, C.W. Binns, and C.D. Holman Body mass index in relation to ovarian cancer survival Cancer Epidemiol Biomarkers Prev 14 5 2005 1307 1310
13. J.Y. Hu, W. Yi, and Y.F. Xia Impact of pretherapy body mass index on prognosis of nasopharyngeal carcinoma Ai Zheng 28 10 2009 1043 1048
14. P.Y. Huang, K.J. Cao, and X. Guo A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma Oral Oncol 48 10 2012 1038 1044
15. L. Tai-Xiang, L. Wei, and Z. Chong A probe of design methods of block shielding facio cervical portals at isocentre for radiotherapy of nasopharyngeal carcinoma Ai Zheng 19 10 2000 930 933
16. M.H. Hong, H.Q. Mai, and H.Q. Min A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma Cancer 89 2 2000 242 247
17. R. Dhanapal, T. Saraswathi, and R.N. Govind Cancer cachexia J Oral Maxillofac Pathol 15 3 2011 257 260
18. E. Van Cutsem, and J. Arends The causes and consequences of cancer-associated malnutrition Eur J Oncol Nurs 9 Suppl 2 2005 S51 S63
19. G. Capuano, P.C. Gentile, and F. Bianciardi Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment Support Care Cancer 18 4 2010 433 437
20. A. Trotti, L.A. Bellm, and J.B. Epstein Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review Radiother Oncol 66 3 2003 253 262
21. A. Nourissat, I. Bairati, and A. Fortin Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer Support Care Cancer 20 3 2012 591 599
22. A.W. Lee, W.H. Lau, and S.Y. Tung Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group J Clin Oncol 23 28 2005 6966 6975
23. M. Ewertz, M.B. Jensen, and K.A. Gunnarsdottir Effect of obesity on prognosis after early-stage breast cancer J Clin Oncol 29 1 2011 25 31
24. Z. Gong, I. Agalliu, D.W. Lin, J.L. Stanford, and A.R. Kristal Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men Cancer 109 6 2007 1192 1202
25. A.W. Lee, J.C. Lin, and W.T. Ng Current management of nasopharyngeal cancer Semin Radiat Oncol 22 3 2012 233 244
26. E.E. Calle, C. Rodriguez, K. Walker-Thurmond, and M.J. Thun Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 17 2003 1625 1638
27. W. Demark-Wahnefried, E.A. Platz, and J.A. Ligibel The role of obesity in cancer survival and recurrence Cancer Epidemiol Biomarkers Prev 21 8 2012 1244 1259
28. D.T. Chua, J.S. Sham, and D.T. Choy Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone Cancer 101 2 2004 307 316
29. Y.H. Li, C.F. Hu, and Q. Shao Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma J Transl Med 6 2008 1
30. D.T. Chua, J.M. Nicholls, J.S. Sham, and G.K. Au Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys 59 1 2004 11 20